Bristol Pravachol U.S. Market Share Is Holding At 15%, Firm Says
The market share of Bristol-Myers Squibb's Pravachol has stabilized at about 15%, the company said during its quarterly sales and earnings teleconference Oct. 19.
The market share of Bristol-Myers Squibb's Pravachol has stabilized at about 15%, the company said during its quarterly sales and earnings teleconference Oct. 19.